Immunology and Biotherapies
20.7K views | +8 today
Follow
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
Scoop.it!

High productivity purification of immunoglobulin G monoclonal ...

High productivity purification of immunoglobulin G monoclonal ... | Immunology and Biotherapies | Scoop.it
We achieved exceptionally high capacity capture of monoclonal IgG by adding 200 nm starch-coated magnetic particles as nucleation centers, adding polyethylene glycol (PEG), then collecting the particle-associated antibody ...
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

EHA Quick Take: Addition of CD20 Monoclonal Antibody to Lenalidomide in Relapsed/Refractory CLL

EHA Quick Take: Addition of CD20 Monoclonal Antibody to Lenalidomide in Relapsed/Refractory CLL | Immunology and Biotherapies | Scoop.it
EHA Quick Take: Addition of CD20 Monoclonal Antibody to Lenalidomide in Relapsed/Refractory CLL. #EHA2014 @ASCOPost http://t.co/grD2rMz4Hy
Gilbert C FAURE's insight:

quick takes from EHA

more...
No comment yet.
Suggested by Krishan Maggon
Scoop.it!

Speeding Up Antiviral T Cell Production | The Scientist Magazine®

Speeding Up Antiviral T Cell Production | The Scientist Magazine® | Immunology and Biotherapies | Scoop.it
Scientists come up with a simpler, more efficient strategy for making multivirus-targeting T cells for immunotherapy.
Gilbert C FAURE's insight:

indeed the challenge is anti-infectious therapy in the context

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Type I and III Interferon Production in Response to RNA Viruses

Type I and III Interferon Production in Response to RNA Viruses | Immunology and Biotherapies | Scoop.it
Gilbert C FAURE's insight:

the paper itsself

more...
No comment yet.
Rescooped by Gilbert C FAURE from NeuroImmunology
Scoop.it!

CSL Behring Announces the 2014 Interlaken Leadership Awards Recipient - Wall Street Journal

CSL Behring Announces the 2014 Interlaken Leadership Awards Recipient - Wall Street Journal | Immunology and Biotherapies | Scoop.it
CSL Behring Announces the 2014 Interlaken Leadership Awards Recipient
Wall Street Journal
"We look forward to the results of Dr.
Gilbert C FAURE's insight:

IVIGs and Guillain Barre syndrome

more...
Gilbert C FAURE's curator insight, June 26, 2014 11:04 AM

Guillain Barre therapy with IVIGs

Scooped by Gilbert C FAURE
Scoop.it!

Engineered T Cells Fight Viral Attacks

Engineered T Cells Fight Viral Attacks | Immunology and Biotherapies | Scoop.it
Broad-spectrum T cells appear to effectively treat the viral infections that commonly follow an hematopoietic stem cell transplant, researchers reported.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Researchers investigate antibody immunotherapy for MERS treatment - Healio

Researchers investigate antibody immunotherapy for MERS treatment - Healio | Immunology and Biotherapies | Scoop.it
Researchers investigate antibody immunotherapy for MERS treatment Healio “In the absence of a licensed vaccine or antiviral for MERS, this panel of [neutralizing antibodies] offers the possibility of developing human monoclonal antibody-based...
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates - MarketWatch

EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates - MarketWatch | Immunology and Biotherapies | Scoop.it
EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates
MarketWatch
... 40 years, EMD Serono has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and access programs.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Probody™ therapeutics for targeting antibodies to diseased tissue, Expert Opinion on Biological Therapy, Informa Healthcare

Probody™ therapeutics for targeting antibodies to diseased tissue, Expert Opinion on Biological Therapy, Informa Healthcare | Immunology and Biotherapies | Scoop.it
Q What are probodies? A the next generation of antibody therapies, find our more in our FREE editorial here http://t.co/80e3KjNFuD...
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Long-Term Outcomes of Kidney Transplantation Across a Positi... : Transplantation

Long-Term Outcomes of Kidney Transplantation Across a Positi... : Transplantation | Immunology and Biotherapies | Scoop.it
BackgroundMore than 30% of potential kidney transplant recipients have pre-existing anti–human leukocyte antigen antibodies. This subgroup has significantly lower transplant rates and increased mortality.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Monoclonal Antibodies Going to the Dogs (and Cats) - 06/19/2014 ...

Monoclonal Antibodies Going to the Dogs (and Cats) - 06/19/2014 ... | Immunology and Biotherapies | Scoop.it
Nexvet is a global biotechnology company developing monoclonal antibodies, but what makes it unusual is that it's developing these therapeutics for pets. Nexvet's platform technology can take a human monoclonal antibody ...
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study - Orandi - 2014 - American Journal of Transplantation - Wiley Online Library

Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study - Orandi - 2014 - American Journal of Transplantation - Wiley Online Library | Immunology and Biotherapies | Scoop.it
RT @mnaesens: Real-life data show that HLA desensitization for positive #kidney #transplantation isn't 1st choice http://t.co/1qXubLBisa
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Orthoclone OKT3 - Life Sciences Foundation

Orthoclone OKT3 - Life Sciences Foundation | Immunology and Biotherapies | Scoop.it
#OnThisDay in 1986, FDA approves Orthoclone - the 1st monoclonal antibody to prevent organ graft rejection. http://t.co/QvdLnpcAd4
Gilbert C FAURE's insight:

making history

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Osiris Therapeutics Inc. | Products - Chondrogen

Osiris Therapeutics Inc. | Products - Chondrogen | Immunology and Biotherapies | Scoop.it
Osiris Therapeutics Inc. description (New stem cell therapy regenerated cartilage at osteoarthrtis. Osiris Therapeutics Inc.
Gilbert C FAURE's insight:

cell therapy in osteoathrosis

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Monoclonal Antibodies Key to Unlocking the Biosimilars Market - The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth. - Bi

Monoclonal Antibodies Key to Unlocking the Biosimilars Market - The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth. - Bi | Immunology and Biotherapies | Scoop.it
The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth. (Approval of monoclonal antibody #biosimilars is necessary if the biosimilars market is to experience real growth.
more...
No comment yet.
Suggested by Société Francaise d'Immunologie
Scoop.it!

Biosimilars of etanercept / General / Biosimilars / Home - GaBI online - Generics and Biosimilars Initiative

Biosimilars of etanercept / General / Biosimilars / Home - GaBI online - Generics and Biosimilars Initiative | Immunology and Biotherapies | Scoop.it
Generics and Biosimilars Initiative
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

TG Therapeutics Inc.: TG Therapeutics Completes Global Licensing Agreement ... - The Wall Street Transcript

TG Therapeutics Inc.: TG Therapeutics Completes Global Licensing Agreement ... - The Wall Street Transcript | Immunology and Biotherapies | Scoop.it
TG Therapeutics Inc.: TG Therapeutics Completes Global Licensing Agreement ...
Gilbert C FAURE's insight:

IRAK as a target

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Guiding Cell Therapy Development - Genetic Engineering News

Guiding Cell Therapy Development - Genetic Engineering News | Immunology and Biotherapies | Scoop.it
Genetic Engineering News Guiding Cell Therapy Development Genetic Engineering News Creating a solid manufacturing and development plan is critical to successfully shepherding a promising cell therapy from discovery to market, but there are still...
more...
No comment yet.
Rescooped by Gilbert C FAURE from Hematology
Scoop.it!

Preclinical Data of Novel Antibody-drug Conjugate IMGN779 Demonstrates Potent Activity Against CD33-expressing Acute Myeloid Leukemia Cells

Preclinical Data of Novel Antibody-drug Conjugate IMGN779 Demonstrates Potent Activity Against CD33-expressing Acute Myeloid Leukemia Cells | Immunology and Biotherapies | Scoop.it
Results from a preclinical trial shows that IMGN779, a novel, DNA-alkylating, anticancer therapeutics based on ImmunoGen, Inc, antibody-drug conjugates (ADC) t… (Data presented at the European Hematology Meeting in Milan, Italy....
more...
No comment yet.
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review
Scoop.it!

Targeting TNFRs with agonist antibodies for cancer therapy: 4-1BB, GITR, CD27

Targeting TNFRs with agonist antibodies for cancer therapy: 4-1BB, GITR, CD27 | Immunology and Biotherapies | Scoop.it
One of the puzzles in thinking about the available costimulatory receptors on T cells (and NK cells) is the unsettling number of them.

Via Krishan Maggon
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Pharmaceutical companies to develop oral cholera vaccine - Ghana Broadcasting Corporation

Pharmaceutical companies to develop oral cholera vaccine - Ghana Broadcasting Corporation | Immunology and Biotherapies | Scoop.it
Ghana Broadcasting Corporation
Pharmaceutical companies to develop oral cholera vaccine
Ghana Broadcasting Corporation
... Laboratories' chief executive officer Davinder Gill said.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Lymphocyte recovery is impaired in patients with... [Ann Hematol. 2014] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Gilbert C FAURE's insight:
chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Can Treg elimination enhance NK cell therapy for AML? [Blood. 2014] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Antibody levels to tetanus, diphtheria, measles and varicela in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study

Background:
Patients with antibody deficiencies depend on the presence of a variety of antibody specificities in intravenous immunoglobulin (IGIV) to ensure continued protection against pathogens.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Scientific Data on Epratuzumab in Systemic Lupus Erythematosus to be ... - GlobeNewswire (press release)

Scientific Data on Epratuzumab in Systemic Lupus Erythematosus to be ...
more...
No comment yet.